Drug Enforcement D-0555-2025

Lack of Processing Controls.

Status

Ongoing

Classification

Class II

Report Date

August 13, 2025

Termination Date

—

Product Information

Product description
Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Product quantity
170 vials
Reason for recall
Lack of Processing Controls.
Recall initiation reason
—
Initial firm notification
E-Mail
Distribution pattern
MA

Location & Firm

Recalling firm
AEQUITA PHARMACY
Address
12825 Ne 126th Pl, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0555-2025
Event ID
97292
Recall initiation date
July 18, 2025
Center classification date
August 1, 2025
Code info
All Lots within expiry.
More code info
—